Tilray Brands (TLRY) Liabilities and Shareholders Equity (2017 - 2026)

Tilray Brands (TLRY) posted Liabilities and Shareholders Equity of $2.1 billion for Q1 2026, down 1.14% on a QoQ basis from $2.1 billion in Q4 2025.

Tilray Brands (TLRY) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Tilray Brands' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $8.3 billion (down 34.28% YoY) and the FY2025 annual result came in at $2.1 billion, down 50.86% from the prior year.
  • Liabilities and Shareholders Equity was $2.1 billion for Q1 2026 at Tilray Brands, down from $2.1 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $5.8 billion in Q1 2022 and bottomed at $2.1 billion in Q2 2025.
  • A 5-year average of $4.1 billion and a median of $4.3 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity decreased 1.99% — and 2025, when it sank 51.13%.
  • Tilray Brands' Liabilities and Shareholders Equity stood at $5.5 billion in 2022, then slipped by 20.89% to $4.3 billion in 2023, then fell by 3.21% to $4.2 billion in 2024, then slumped by 49.94% to $2.1 billion in 2025, then dropped by 1.14% to $2.1 billion in 2026.
  • Business Quant data shows TLRY's Liabilities and Shareholders Equity at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn 2.07 Bn

Historic Data

Download Data
DateValue
Feb 28, 2026 2.07 Bn
Nov 30, 2025 2.10 Bn
Aug 31, 2025 2.08 Bn
May 31, 2025 2.07 Bn
Nov 30, 2024 4.19 Bn
Aug 31, 2024 4.26 Bn
May 31, 2024 4.22 Bn
Feb 29, 2024 4.21 Bn
Nov 30, 2023 4.33 Bn
Aug 31, 2023 4.40 Bn
May 31, 2023 4.31 Bn
Feb 28, 2023 4.38 Bn
Nov 30, 2022 5.47 Bn
Aug 31, 2022 5.59 Bn
May 31, 2022 5.45 Bn
Feb 28, 2022 5.82 Bn
Nov 30, 2021 5.76 Bn
Aug 31, 2021 5.99 Bn
May 31, 2021 6.03 Bn
May 31, 2020 1.74 Bn